- $12.80bn
- $30.33bn
- $3.27bn
- 62
- 37
- 85
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,961 | 2,766 | 2,889 | 3,109 | 3,274 |
Cost of Revenue | |||||
Gross Profit | 1,866 | 1,724 | 1,842 | 1,958 | 2,040 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,969 | 1,860 | 1,966 | 2,050 | 2,239 |
Operating Profit | 992 | 905 | 923 | 1,059 | 1,034 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 652 | 1,019 | 632 | 1,021 | 291 |
Net Income After Taxes | 652 | 1,019 | 632 | 1,021 | 291 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 522 | 873 | 505 | 849 | 190 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 511 | 862 | 496 | 848 | 190 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.65 | 1.57 | 2.7 | 2.57 | 1.23 |
Dividends per Share |